ReviewBone marrow transplantation2025
Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia.
Mary R Christopher et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it